A new study suggests a potassium channel blocker nasal spray could reduce the severity of sleep apnea.
The company came to an agreement with the FDA to cease sales until the machines’ health hazards can be fully addressed.
Philips faces new FDA scrutiny over life-threatening defects of its DreamStation 2 CPAP.
A new study suggests a potassium channel blocker nasal spray could reduce the severity of sleep apnea.
The company came to an agreement with the FDA to cease sales until the machines’ health hazards can be fully addressed.
Philips faces new FDA scrutiny over life-threatening defects of its DreamStation 2 CPAP.